MedTrace Logo

Effects of Banned Substances on Some Metabolic Functions in Male Amateur Athletes

NCT06823011 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-02-12

No results posted yet for this study

Summary

The aim of this study was to investigate the effects of banned substances on some metabolic functions in male athletes in order to raise awareness among individuals who use these substances by highlighting the potential harms of using banned substances to draw attention to the issue and raise awareness. 2) Methods: The study is a randomised cross-sectional study. The study included 20 male amateur athletes who had actively practised bodybuilding, arm wrestling, powerlifting and weightlifting in the last 5 years and had not participated in competitions. The study group consisted of 10 adult male amateur athletes who had used banned substances at least once a year in the past 5 years, while 10 male amateur athletes who had not used banned substances with similar qualifications formed the control group. Participants were included in the study on a voluntary basis. Participants' age, sports age, height, weight and BMI variables were selected and parameters related to liver, kidney, hormone and lipid profiles were determined. The Shapiro-Wilk test was used to test the normality of the values obtained from the data. The independent t-test was used for the data showing a normal distribution and the Mann Whitney U- test was used for the data not showing a normal distribution.

Conditions

  • Effects of Banned Substances

Interventions

DIAGNOSTIC_TEST

blood collection

Blood was collected from the study group and the control group at 10 am in the morning on an empty stomach.

Sponsors & Collaborators

  • Hitit University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-15
Primary Completion
2024-07-15
Completion
2024-08-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06823011 on ClinicalTrials.gov